Literature DB >> 28397825

Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences.

Chris J L M Meijer1, Renske D M Steenbergen1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28397825     DOI： 10.1038/nrclinonc.2017.52

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  11 in total

1.  miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.

Authors:  Fenfen Wang; Yang Li; Jiansong Zhou; Junfen Xu; Chanjuan Peng; Feng Ye; Yuanming Shen; Weiguo Lu; Xiaoyun Wan; Xing Xie
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

2.  A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).

Authors:  P H Thaker; R Salani; W E Brady; H A Lankes; D E Cohn; D G Mutch; R S Mannel; K M Bell-McGuinn; P A Di Silvestro; D Jelovac; J S Carter; W Duan; K E Resnick; D S Dizon; C Aghajanian; P M Fracasso
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

3.  APOBEC3A functions as a restriction factor of human papillomavirus.

Authors:  Cody J Warren; Tao Xu; Kejun Guo; Laura M Griffin; Joseph A Westrich; Denis Lee; Paul F Lambert; Mario L Santiago; Dohun Pyeon
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

4.  Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Authors:  Yasuki Kusanagi; Atsumi Kojima; Yoshiki Mikami; Takako Kiyokawa; Tamotsu Sudo; Satoshi Yamaguchi; Ryuichiro Nishimura
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

5.  Improved survival with bevacizumab in advanced cervical cancer.

Authors:  Krishnansu S Tewari; Michael W Sill; Harry J Long; Richard T Penson; Helen Huang; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J Reid; Mario M Leitao; Helen E Michael; Bradley J Monk
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

6.  Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.

Authors:  Mariska Bierkens; Oscar Krijgsman; Saskia M Wilting; Leontien Bosch; Annelieke Jaspers; Gerrit A Meijer; Chris J L M Meijer; Peter J F Snijders; Bauke Ylstra; Renske D M Steenbergen
Journal:  Genes Chromosomes Cancer       Date:  2012-09-14       Impact factor: 5.006

7.  HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.

Authors:  L Rodríguez-Carunchio; I Soveral; R D M Steenbergen; A Torné; S Martinez; P Fusté; J Pahisa; L Marimon; J Ordi; M del Pino
Journal:  BJOG       Date:  2014-09-17       Impact factor: 6.531

8.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

9.  Integrated genomic and molecular characterization of cervical cancer.

Authors: 
Journal:  Nature       Date:  2017-01-23       Impact factor: 49.962

10.  MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women.

Authors:  Qifang Tian; Yang Li; Fenfen Wang; Ying Li; Junfen Xu; Yuanming Shen; Feng Ye; Xinyu Wang; Xiaodong Cheng; Yaxia Chen; Xiaoyun Wan; Weiguo Lu; Xing Xie
Journal:  J Natl Cancer Inst       Date:  2014-09-04       Impact factor: 13.506
View more
  5 in total

1.  CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.

Authors:  Xiaoxi Zhang; Yunxia Sun; Siyao Cheng; Yanjing Yao; Xintao Hua; Yueyue Shi; Xiaoqin Jin; Jieli Pan; Miaofen G Hu; Pian Ying; Xiaoli Hou; Daozong Xia
Journal:  Cell Cycle       Date:  2022-02-15       Impact factor: 5.173

Review 2.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

3.  Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.

Authors:  Marcela Nunes Rosa; Adriane Feijó Evangelista; Letícia Ferro Leal; Cristina Mendes De Oliveira; Viviane Aline Oliveira Silva; Carla Carolina Munari; Fernanda Franco Munari; Graziela De Macêdo Matsushita; Ricardo Dos Reis; Carlos Eduardo Andrade; Cristiano de Pádua Souza; Rui Manuel Reis
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

4.  Identification and Validation of Autophagy-Related Gene Nomograms to Predict the Prognostic Value of Patients with Cervical Cancer.

Authors:  Jinqun Jiang; HongYan Xu; YiHao Wang; Hai Lu
Journal:  J Oncol       Date:  2021-06-25       Impact factor: 4.375

5.  Adenosquamous Carcinoma of the Uterine Cervix - Impact of Histology on Clinical Management.

Authors:  Angel Yordanov; Stoyan Kostov; Stanislav Slavchev; Strahil Strashilov; Assia Konsoulova; Jean Calleja-Agius; Riccardo Di Fiore; Sherif Suleiman; Paul Kubelac; Catalin Vlad; Patriciu Achimas-Cadariu; Mariela Vasileva-Slaveva
Journal:  Cancer Manag Res       Date:  2021-06-23       Impact factor: 3.989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.